Ax-003/Arimidex (Anastrozole) in the Adjuvant Therapy of Early Breast Cancer

Letrozole as Early Adjuvant Treatment of Postmenopausal Patients With Primary Breast Cancer

NCT00332852 ·Status: COMPLETED ·Phase: PHASE3

Arthralgia During Anastrozole Therapy for Breast Cancer

NCT00323479 ·Status: COMPLETED ·Phase: PHASE4

Different Durations of Adjuvant Anastrozole Therapy After 2 to 3 Years Tamoxifen Therapy in Breast Cancer

NCT00301457 ·Status: COMPLETED ·Phase: PHASE3

Study on Pre-menopausal Patients With Advanced ER and PR + BC Treated With Arimidex Plus Zoladex

NCT00235937 ·Status: COMPLETED ·Phase: PHASE2

Effectiveness of Combination of Arimidex and Nolvadex in Adjuvant Therapy of Breast Carcinoma in Postmenopausal Women.

NCT00287534 ·Status: COMPLETED ·Phase: PHASE2

Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer

NCT01151215 ·Status: TERMINATED ·Phase: PHASE2

Comparing Anastrozole-Placebo to the Combination Anastrozole-ZD1839 in Postmenopausal Patients With Estrogen Receptor and/or Progesterone Receptor Metastatic Breast Cancer

NCT00077025 ·Status: COMPLETED ·Phase: PHASE2

Survey Conducted Among Early Breast Cancer Patients Treated With Arimidex for Evaluation of Treatment Adherence

NCT01081509 ·Status: COMPLETED

Survey in Post-menopausal Women Followed up After Treatment With Anastrozole as Adjuvant Therapy

NCT00542594 ·Status: TERMINATED

Anastrozole in Preventing Breast Cancer in Postmenopausal Women at Increased Risk of Breast Cancer

NCT00078832 ·Status: COMPLETED ·Phase: PHASE3

Anastrozole With or Without Gefitinib in Treating Postmenopausal Women With Metastatic or Locally Recurrent Breast Cancer

NCT00066378 ·Status: COMPLETED ·Phase: PHASE2

Gene Expression Following Short Term Exposure to Neoadjuvant Endocrine Therapy in Invasive Breast Cancer

NCT00588003 ·Status: COMPLETED ·Phase: PHASE1

CONcurrent vs SEqueNTial Adjuvant Treatments in Early Breast Cancer

NCT02918084 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Breast Cancer Tumor Care Observational Programme

NCT00660244 ·Status: COMPLETED

Arimidex/Tamoxifen Neo Adjuvant Study in Premenopausal Patients With Breast Cancer Under Anti Hormonal Treatment

NCT00605267 ·Status: COMPLETED ·Phase: PHASE3

Raloxifene and Goserelin in Preventing Breast Cancer in Women With a Family History of Breast Cancer

NCT00031850 ·Status: COMPLETED ·Phase: NA

Estradiol Suppression for the Treatment of Metastatic Breast Cancer in Premenopausal Women

NCT00186121 ·Status: COMPLETED ·Phase: PHASE2

Chemoprevention Trial - Anastrozole in Ductal Carcinoma In Situ (DCIS) in Postmenopausal Women

NCT00256217 ·Status: COMPLETED ·Phase: PHASE2

CDK4/6 Inhibitors Combined With Standard Adjuvant Endocrine Therapy in High-Risk, HR+/HER2+ Early Breast Cancer Patients(CHESS)

NCT07019363 ·Status: RECRUITING ·Phase: PHASE3

This is a Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study Evaluating the Efficacy and Safety of FCN-437c Versus Placebo in Combination With Letrozole or Anastrozole ± Goserelin in Women With HR+ and HER2- Advanced Breast Cancer.

NCT05439499 ·Status: UNKNOWN ·Phase: PHASE3

Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer

NCT00382070 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Study of Nonsteroidal Aromatase Inhibitors Plus Abemaciclib (LY2835219) in Postmenopausal Women With Breast Cancer

NCT02246621 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Anastrozole Monotherapy Versus Maximal Oestrogen Blockade With Anastrozole and Fulvestrant Combination Therapy

NCT00256698 ·Status: COMPLETED ·Phase: PHASE3

Adjuvant Hormone Therapy in Treating Women With Operable Breast Cancer

NCT00002460 ·Status: UNKNOWN ·Phase: PHASE3

Radiotherapy - Anastrazole Concomitant : Evaluation of the Side Effects

NCT01183832 ·Status: COMPLETED